Study examines risk of bleeding among patients taking 2 anti-platelet drugs

treatment with the medications clopidogrel and aspirin together to prevent blood clots—poses a clinically significant risk of hemorrhage that should be considered before prescribing, according to a report in the November 22 issue of Archives of Internal Medicine.

Read the whole article on Physorg

More from Physorg